# Celecoxib in Treating Women With Metastatic or Recurrent Breast Cancer

> **NCT00045591** · PHASE2 · TERMINATED · sponsor: **Alliance for Clinical Trials in Oncology** · enrollment: 39 (actual)

## Conditions studied

- Breast Cancer

## Interventions

- **DRUG:** celecoxib
- **DRUG:** Celecoxib

## Key facts

- **NCT ID:** NCT00045591
- **Lead sponsor:** Alliance for Clinical Trials in Oncology
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** TERMINATED
- **Start date:** 2003-02
- **Primary completion:** 2005-08
- **Final completion:** 2010-01
- **Target enrollment:** 39 (ACTUAL)
- **Last updated:** 2017-01-11

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00045591

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00045591, "Celecoxib in Treating Women With Metastatic or Recurrent Breast Cancer". Retrieved via AI Analytics 2026-06-03 from https://api.ai-analytics.org/clinical/NCT00045591. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*